Wistar-Kyoto rats are sensitive to the hypolocomotor and anxiogenic effects of mCPP

Behavioural Pharmacology

Volumn 14, Issue 2, 2003, Pages 173-177

  Durand, M ^a   Mormede P ^a   Chaouloff, F ^a,b  

^a INSERM   (France)

^b INSTITUT FRANÇOIS MAGENDIE   (France)

Author keywords

5 HT2B 2C receptors; Anxiety; Elevated plus maze; Locomotion; mCPP; SB 206553; Spontaneously hypertensive rats; Wistar Kyoto rats

Indexed keywords

1,2,3,5 TETRAHYDRO 5 METHYL 1 (3 PYRIDYLCARBAMOYL)PYRROLO[2,3 F]INDOLE; 6 CHLORO 5 METHYL 1 [[2 [(2 METHYL 3 PYRIDYL)OXY] 5 PYRIDYL]CARBAMOYL]INDOLINE; CITALOPRAM; FLUOXETINE; SEROTONIN UPTAKE INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANXIETY; ARTICLE; CONTROLLED STUDY; DESENSITIZATION; DRUG EFFECT; FORCED SWIMMING TEST; LOCOMOTION; MALE; MAZE TEST; NONHUMAN; POSTSYNAPTIC INHIBITION; PRINCIPAL COMPONENT ANALYSIS; RAT; REINFORCEMENT; SOCIAL INTERACTION; SPONTANEOUSLY HYPERTENSIVE RAT; STIMULUS RESPONSE; STRAIN DIFFERENCE; TRANQUILIZING ACTIVITY;

EID: 0037366752     PISSN: 09558810     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008877-200303000-00010     Document Type: Article

References (24)

1. Armario A, Gavalda A, Marti J (1995). Comparison of the behavioral and endocrine responses to forced swimming stress in five inbred rat strains of rats. Psychoneuroendocrinology 20:879-890.
2. Cruz APM, Frei F, Graeff FG (1994). Ethopharmacological analysis of rat behavior on the elevated plus-maze. Pharmacol Biochem Behav 49:171-176.
3. 2C receptors. Neuropharmacology 39:1114-1117.
4. Durand M, Aguerre S, Fernandez F, Edno L, Combourieu I, Mormède P, Chaouloff F (2000). Strain-dependent neurochemical and neuroendocrine effects of desipramine, but not fluoxetine or imipramine, in Spontaneously Hypertensive and Wistar-Kyoto rats. Neuropharmacology 39:2464-2477.
5. File SE (1991) The biological basis of anxiety. In: Meltzer HY, Nerozzi D (editors): Current Practices and Future Developments in the Pharmacotherapy of Mental Disorders. Amsterdam: Elsevier, pp. 159-165.
6. Gentsch C, Lichtsteiner M, Feer H (1987). Open field and elevated plus-maze: a behavioural comparison between spontaneously hypertensive (SHR) and Wistar-Kyoto (WKY) rats and the effects of chlordiazepoxide. Behav Brain Res 25:101-107.
7. 2B receptors. Behav Pharmacol 12:613-620.
8. 2 receptor subtype antagonists in rat and mouse models of anxiety. Neuropharmacology 36:793-802.
9. Griebel G, Cohen C, Perrault G, Sanger DJ (1999). Behavioral effects of acute and chronic fluoxetine in Wistar-Kyoto rats. Physiol Behav 6:315-320.
10. 2B receptor agonist, BW 723C86, on three rat models of anxiety. Br J Pharmacol 117:1443-1448.
11. 2B receptor antagonist with anxiolytic-like activity. Br J Pharmacol 117:427-434.
12. 2C receptor antagonist. Neuropharmacology 36:609-620.
13. Lahmame A, Del Arco C, Pazos A, Yritia M, Armario A (1997). Are Wistar-Kyoto rats a genetic animal model of depression resistant to antidepressants? Eur J Pharmacol 337:115-123.
14. Lopez-Rubalcava C, Lucki I (2000). Strain differences in the behavioral effects of antidepressant drugs in the rat forced swimming test. Neuropsychopharmacology 22:191-199.
15. Millan MJ, Brocco M, Gobert A, Dorey G, Casara P, Dekeyne A (2001). Anxiolytic properties of the selective, non-peptidergic CRF(1) antagonists, CP154,526 and DMP695: a comparison to other classes of anxiolytic agent. Neuropsychopharmacology 25:585-600.
16. Okamoto K, Aoki K (1963). Development of a strain of spontaneously hypertensive rats. Jpn Circ J 27:282-293.
17. Paré WP (1994). Open field, learned helplessness, defensive burying, and forced-swim tests in WKY rats. Physiol Behav 55:433-439.
18. Pollier F, Sarre S, Aguerre S, Ebinger G, Mormède P, Michotte Y, Chaouloff F (2000). Serotonin reuptake inhibition by citalopram in rat strains differing for their emotionality. Neuropsychopharmacology 22:64-76.
19. Ramos A, Mormède P (1998). Stress and emotionality: a multidimensional and genetic approach. Neurosci Biobehav Rev 22:33-57.
20. Ramos A, Berton O, Mormède P, Chaouloff F (1997). A multiple test study of anxiety-related behaviours in six inbred rat strains. Behav Brain Res 85:57-69.
21. Rodgers RJ, Johnson JT (1995). Factor analysis of spatiotemporal and ethological measures in the murine elevated plus-maze test of anxiety. Pharmacol Biochem Behav 52:297-303.
22. Rotzinger S, Fang J, Coutts RT, Baker GB (1998). Human CYP2D6 and metabolism of m-chlorophenylpiperazine. Biol Psychiatry 44:1185-1191.
23. Söderpalm B (1989). The SHR exhibits less 'anxiety' but increased sensitivity to the anticonflict effect of clonidine compared to normotensive controls. Pharmacol Toxicol 65:381-386.
24. 2B/2C receptor antagonist SB 206553 in spontaneously hypertensive and Lewis rats tested in the elevated plus-maze. Braz J Med Biol Res 34:675-682.